問卷

TPIDB > Principal Investigator

Principal Investigator


National Taiwan University Hospital (在職)

Division of Nephrology

Division of General Internal Medicine

Division of Ophthalmology

更新時間:2023-09-19

謝易庭
  • Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

24Cases

2026-02-01 - 2028-05-31

Phase II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

2021-11-01 - 2031-12-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Recruiting5Sites

2013-01-01 - 2022-12-31

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Not yet recruiting2Sites

Recruiting3Sites

2015-10-15 - 2018-04-30

Phase III

A Two-Year, Randomized, Double-Masked, Multicenter, Two-Arm Study Comparing the Efficacy and Safety of RTH258 6 mg Versus Aflibercept in Subjects with Neovascular Age-Related Macular Degeneration
  • Condition/Disease

    Neovascular Age-Related Macular Degeneration

  • Test Drug

    RTH258

Participate Sites
5Sites

Terminated5Sites

1 2 3